UKPDS - modelling of cardiovascular risk assessment and lifetime simulation of outcomes

被引:20
作者
Adler, A. I. [1 ]
机构
[1] Addenbrookes Hosp, Inst Metab Sci, Cambridge CB2 2QQ, England
关键词
cardiovascular disease; epidemiology; health economics; modelling;
D O I
10.1111/j.1464-5491.2008.02498.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although known principally, as a clinical trial, the UK Prospective Diabetes Study (UKPDS) provided longitudinal data which helped define the natural history of cardiovascular complications in Type 2 diabetes. Using clinical, epidemiological, statistical and economics methods, UKPDS investigators developed mathematical models that helped define predictors (risk factors) for cardiovascular disease including angina, myocardial infarction, stroke, peripheral Vascular disease and death in Type 2 diabetes. The UKPDS made clearer the contributions to risk of age, hyperglycaemia, elevated blood pressure, adverse blood lipids and smoking. Equations were developed, combined and incorporated into the UKPDS Risk Engine and the UKPDS Outcomes models. For example, the UKPDS risk engine-version 2-estimates that a white 62-year-old man with 11 years of Type 2 diabetes, a glycated haemoglobin of 8.3%, a systolic blood pressure of 145 mmHg and total and high-density lipoprotein cholesterol values of 5.8 and 1.1 mmol/l who did not smoke has a 33% chance of having overt coronary heart disease within 10 years. These models Contribute to the estimation of risk and/or health outcomes adjusted for quality of life for use by, amongst others, clinicians, trialists, health planners, guideline developers and health economists.
引用
收藏
页码:41 / 46
页数:6
相关论文
共 50 条
  • [41] Childhood Obesity and Adulthood Cardiovascular Disease Quantifying the Lifetime Cumulative Burden of Cardiovascular Risk Factors
    Litwin, Sheldon E.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (15) : 1588 - 1590
  • [42] Lifetime History of Smoking, Cessation and the Risk of Cardiovascular Disease: Prospective Results From the Framingham Heart Study
    Duncan, Meredith S.
    Freiberg, Matthew S.
    Greevy, Robert
    Kundu, Suman
    Vasan, Ramachandran S.
    Tindle, Hilary A.
    [J]. CIRCULATION, 2018, 138
  • [43] Update and validation of the lifetime cardiovascular risk in Spain: IBERLIFERISK2
    Brotons, Carlos
    Moral-Pelaez, Irene
    Vicuna, Johanna
    Ameixeiras, Cristina
    Fernandez-Lavandera, Carlos
    Sanchez-Chaparro, Miguel Angel
    [J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2023, 35 (03): : 115 - 122
  • [44] The Role of Emerging Risk Factors in Cardiovascular Outcomes
    Ben Lacey
    William G. Herrington
    David Preiss
    Sarah Lewington
    Jane Armitage
    [J]. Current Atherosclerosis Reports, 2017, 19
  • [45] Diet Quality and Lifetime Risk of Total Cardiovascular Disease in US Adults
    Zhong, Victor W.
    Ning, Hongyan
    Van Horn, Linda V.
    Wilkins, John T.
    Lloyd-Jones, Donald M.
    Allen, Norrina B.
    [J]. CIRCULATION, 2018, 137
  • [46] The Role of Emerging Risk Factors in Cardiovascular Outcomes
    Lacey, Ben
    Herrington, William G.
    Preiss, David
    Lewington, Sarah
    Armitage, Jane
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2017, 19 (06)
  • [47] Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease
    McVeigh, G. E.
    Gibson, W.
    Hamilton, P. K.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (03) : 198 - 203
  • [48] Adverse pregnancy outcomes, familial predisposition, and cardiovascular risk: a Swedish nationwide study
    Mantel, Angla
    Wollmann, Charlotte Lindblad
    Faxen, Jonas
    Sandstrom, Anna
    Muhlrad, Hanna
    Stephansson, Olof
    [J]. EUROPEAN HEART JOURNAL, 2025, 46 (08) : 733 - 745
  • [49] Association between perceived lifetime risk of cardiovascular disease and calculated risk in a male population in Brazil
    de Lima, Mario Maciel, Jr.
    da Silva, Glaciane Rocha
    Jensem Filho, Sebastiao Salazar
    Granja, Fabiana
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2016, 12 : 279 - 286
  • [50] Estimation of Lifetime Risk of Cardiovascular Disease (IBERLIFERISK): A New Tool for Cardiovascular Disease Prevention in Primary Care
    Brotons, Carlos
    Moral, Irene
    Fernandez, Diana
    Puig, Mireia
    Calvo Bonacho, Eva
    Martinez Munoz, Paloma
    Catalina Romero, Carlos
    Quevedo Aguado, Luis Javier
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (07): : 562 - 568